About US
Contact us
-
After Pfizer deal, Sanofi offers a hand to Johnson & Johnson for COVID-19 vaccine productionSanofi hasn't abandoned its COVID-19 vaccine hopes despite a setback in the high-stakes race, but as it moves two different shots forward, it's also pitching in to make doses for its usualrivals. The2021/2/23
-
Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buyJust a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to tap that expertise. Charles River Laboratories agreed t2021/2/19
-
Inspectors force AstraZeneca's Mexico vaccine partner to overhaul its factory, holding up shot productionWhile Mexico is receiving small shipments of AstraZeneca's COVID-19 vaccines from overseas, two large shipments of the active ingredient used to make it remain unused. The holdup? Problems at a domes2021/2/19
-
AstraZeneca, Oxford race to update COVID-19 vaccine as study flags weak action against variantIt didn’t take long before a morale boost forAstraZeneca’s COVID-19 vaccine was overshadowed by disappointment over itswaned protection against a newly emerged coronavirus variant. A new study has fo2021/2/9
-
Novartis' 2021 access goal: solutions as 'innovative as the science itself'Novartis has a busy year ahead withdrug launches and pre-launch prep for late-stage pipeline products, but at the same time, the company is making an effort to think differently about improving patie2021/2/9
-
Gilead sees a blockbuster 2021 for COVID-19 drug Veklury but can grow without it: CFOEarly in the COVID-19 pandemic, as researchers scrambled to find medicines that could treat the new and mysterious disease, Gilead Sciences' remdesivir quickly marched to worldwide prominence based o2021/2/7
-
No need 'to start at square one': FDA plans to lay out a speedy path for COVID-19 vaccines, drugs against variantsNew coronavirus variants have prompted COVID-19 vaccine makers to start developing updates to their existing offerings. To speed their journey to a pandemic-fatigued public, the FDA says it’s develop2021/2/7
-
Could combining Pfizer's and AZ's COVID-19 vaccines fill supply gaps? U.K. researchers aim to find outGiven that the COVID-19 vaccines from Pfizer and AstraZeneca each require one dose, followed a few weeks later by a booster shot, could the two products be used interchangeably? That’s the question r2021/2/5
-
Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral medsNovo Nordisk is off and running with its launch for oral semaglutide, a Type 2 diabetes med carrying blockbuster expectations. But the company also sees potential new uses for its oral delivery platf2021/2/5
-
Pfizer's new rare-disease meds Vyndaqel, Vyndamax reach blockbuster threshold despite pandemic hurdlesWhile the COVID-19 pandemic dominated headlines at Pfizer and beyond last year, behind the scenes, the company has been busy with its launch of rare heart diseasemedsVyndaqelandVyndamax. And those ef2021/2/3